CA Patent

CA2784587A1 — Orally administrable film dosage forms containing ondansetron

Assigned to Aquestive Therapeutics Inc · Expires 2011-07-28 · 15y expired

What this patent protects

The invention relates to orally administrable, disintegrating film dosage forms which include ondansetron and methods of orally administering the film dosage forms.

USPTO Abstract

The invention relates to orally administrable, disintegrating film dosage forms which include ondansetron and methods of orally administering the film dosage forms.

Drugs covered by this patent

Patent Metadata

Patent number
CA2784587A1
Jurisdiction
CA
Classification
—
Expires
2011-07-28
Drug substance claim
No
Drug product claim
No
Assignee
Aquestive Therapeutics Inc
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.